Eastern Europe and Central Asia are major global hotspots for multidrug-resistant
tuberculosis (MDR-TB), according to a new report by the World Health Organization
(WHO). Tuberculosis patients in these regions are 10 times more likely to
have drug-resistant TB than their counterparts in the rest of the world (http://www.who.int/tb/publications/global_report/en/).
Six of the top 10 global hot spots are in countries from the former
Soviet Union, and have resistance rates in newly diagnosed patients as high
as 14%. Other nations with relatively high levels of MDR-TB include China,
Ecuador, Israel, and South Africa.
Stephenson J. Multidrug-Resistant TB. JAMA. 2004;291(15):1826. doi:10.1001/jama.291.15.1826-a
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: